A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"
Background: The raising prevalence of type-2 diabetes mellitus and obesity has been recognized as a major problem for public health, affecting both developed and developing countries. Impaired fasting plasma glucose has been previously associated with endothelial dysfunction, higher levels of inflam...
Saved in:
Institution: | Universidad EIA |
---|---|
Main Authors: | , , , , , |
Format: | Artículo de revista |
Language: | English |
Published: |
2006-09-07
|
Subjects: | |
Online Access: | https://repositorio.udes.edu.co/handle/001/3296 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|